Intrinsiqq
Neumora Therapeutics, Inc. logo

Neumora Therapeutics, Inc.

NMRA

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$63M
EPS-$1.06
P/E-0.31
P/FCF-0.38
EV/EBITDA-0.49
FCF Yield–
Div. Yield–
Net Debt/FCF-0.2x
Neumora Therapeutics, Inc. intrinsic value
52-Week Range
$0.33$1.00

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$190M

▲ +2.8% YoY

Op. Margin

–

ROIC

-85.27%

▼ -20.5pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$167M

▼ -12.8% YoY

Op. Cash Flow (TTM)

-$167M

▼ -12.8% YoY

Net Debt

$28M

Cash & Equiv.

$86M

Continue Research

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with NMRA

CompareIntrinsic value
TILInstil Bio, Inc.
$5.23-5.77%10
IVVDInvivyd Inc.
$0.41-7.47%10
LXEOLexeo Therapeutics Inc.
$2.96+0.34%10
ELOXEloxx Pharmaceuticals, Inc.
$10.75+0.94%20
CLDICalidi Biotherapeutics Inc.
$0.48-5.45%19
INBXInhibrx Biosciences, Inc.
$68.97-7.21%18
CRISCuris Inc.
$0.44-7.21%35
DYAIDyadic International Inc.
$0.29-6.45%25

Held by ETFs

NMRA is in 5 US ETFs. The largest of them, with NMRA's weight in each:

Neumora Therapeutics (NMRA) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.31
Negative: a loss over the last twelve months. Price to free cash flow -0.38.
Financials

Questions about Neumora Therapeutics

Does Neumora Therapeutics (NMRA) pay a dividend?

No. Neumora Therapeutics (NMRA) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 11 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in NMRA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NMRA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.